 (nm) Figure S1 . A) Chemical structure of PQQ and of its doubly reduced form. B) Absorbance spectra of (blue line) holo ox -sGDH (5.0 µM monomeric binding site or subunit) determined after 30 min preincubation at room temperature of apo-sGDH with 2-fold excess of PQQ followed by gel filtration on a PD10 column, and of (red Figure S3 . Effect of CaCl 2 concentration on the amplitude A 1 and A 2 associated to each of the two kinetic phases recorded during the transition of apo-sGDH to holo red . The experimental conditions were the same than in Figure 1C . The amplitudes were inferred from the fit of a biexponential function to the stopped-flow kinetics traces. The blue and red solid lines correspond to the best fits of a binding isotherm to the blue and red experimental data, respectively, leading both to a same apparent equilibrium constant = 2.0 ± 0. Figure S4 . Plots of k 1,obs and k 2,obs as a function of PQQ concentration (for k 1,obs only pseudo-first order conditions in PQQ were considered). The green square data were recovered from the absorbance change at 338 nm, while the red triangle data were obtained from the quenching of tryptophan emission fluorescence at 340 nm. The experimental conditions for absorbance change at 338 nm were the same than those reported in Figure   1A , while for the quenching of fluorescence they were the same than those in Figure 3A . Figure S5 . Fluorescence spectra of 5 µM apo-sGDH subunit before (red curve) and after addition of 10 µM PQQ (blue curve). The UV-visible absorption spectra of apo-sGDH is also added for comparison (black curve).
The excitation was performed at  ex =297 nm. Ca 2+ present in solution) obtained upon sequential conversion at room temperature of (black curve) apo-sGDH (5 µM subunit) to (blue curve) holoX ox , followed by (green curve) holoX red converted then (red curve) to holo red .
After recording the spectrum of apo-sGDH, 2-fold excess of PQQ was added to the apo-sGDH solution leading instantaneously to the spectrum of holoX ox (blue curve). Then, 2 mM D-glucose was added to the holoX ox solution leading to a change in the spectrum (completed within a few minutes) corresponding to holoX red (green curve). Finally, 2 mM CaCl 2 was added to the holoX red solution leading rapidly to the spectrum of holo red (red curve). Table S2 . Observed rates and absorbance difference amplitudes extracted from the fits of a biexponential function to the experimental kinetics plots of Figure 1C .
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[ In these experiments, the pre-incubation of either apo-sGDH (wild-type or mutated sGDH) with CaCl 2 in syringe 1 or PQQ with CaCl 2 in syringe 2, or even in both syringes before mixing, were tested to verify if there is an effect on the observed rates k 1,obs and k 2,obs determined for the wild-type and the P248A mutant-type sGDH. This was achieved by monitoring either the enzyme activation through the absorbance change at 338 nm or the tryptophan fluorescence quenching at 335 nm. The final concentrations for all experiments were 2.5 µM apo-GDH subunit, 5 µM PQQ and 3 mM CaCl 2 in 50 mM TRIS buffer pH 7.5. The temperature was maintained at 10°C. 
